Jump to content
Powered by

Diagnostics

The latest articles, press releases and dossiers on diagnostics in Baden-Württemberg

  • Article - 17/05/2016

    The revision of the European legislation on medical devices is aimed at making medical devices safer and rebuilding the trust of patients. Rather than implementing the system change that was being planned after the silicone breast implant scandal in 2010, the EU called for open public consultation to prevent such incidents from occurring. As a result, revision of the legislation has been ongoing since autumn 2012.

  • Article - 09/05/2016

    When soft tissue is transplanted, for example in a patient undergoing tumour surgery, care must be taken to ensure that the new tissue is connected to the blood system in the area where the tumour has been removed. How well this works is difficult to find out, especially in the case of deep-seated defects. Partially implantable microsensor probes called FlexiTel have the potential to improve this situation by monitoring success during the first…

  • Article - 25/04/2016

    Pancreatic tumours are among the cancers with the worst prognosis. In many cases they are resistant to treatment. Prof. Dr. Andreas Trumpp and his colleagues from the DKFZ and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine HI-STEM have discovered that the reason why some pancreatic tumours are so resistant to treatment is down to larger quantities of the enzyme CYP3A5 in subtypes of pancreatic cancer. Molecular…

  • Dossier - 18/04/2016

    Epigenetics, i.e. the inheritance of traits that does not involve a change in the DNA sequence, was once a controversial subject that has since become a central focus of biological research. Epigenetic inheritance is now studied by numerous national and international research programmes. Many cellular regulatory and differentiation processes are controlled by epigenetic mechanisms that take place on different levels, including the DNA, histone,…

  • Article - 14/04/2016

    Bacteria or fungi that have caused an infection need to be detected as rapidly as possible in order to save the lives of people with serious and life-threatening complications. Up until now, blood cultures have been used to detect the presence of pathogens. However, such tests take far too long and often do not provide an unambiguous result. In cooperation with industrial partners, researchers at the Fraunhofer Institute for Interfacial…

  • Article - 24/03/2016

    The Meet & Match event “Optical Imaging: Future Trends in Medical Applications” – organised by BIOPRO Baden-Württemberg GmbH and the Fraunhofer Project Group for Automation in Medicine and Biotechnology (PAMB) in Mannheim on 9th March 2016 - attracted around 80 participants. Interesting lectures provided in-depth insights into future trends in optical imaging in medical applications.

  • Article - 14/03/2016

    Being able to diagnose and treat tumour patients in just a few hours is just one of the many promising goals of the Fraunhofer Project Group for Automation in Medicine and Biotechnology (PAMB). The overall goal of the Intervention and Therapy research group is to take innovative technologies for diagnostic and therapeutic interventions from laboratory development to prototype production for use in clinical trials. Such technologies could range…

  • Article - 03/03/2016

    Researchers around the world, including researchers from the Freiburg University Medical Center, are working on developing simple blood tests, so-called liquid biopsies, that can be used to obtain accurate information about tumour staging and the progress of therapy. An international liquid biopsy symposium was held in Freiburg in October 2015 and has produced valuable insights.

  • Article - 02/02/2016

    EIT Health is a large-scale European project launched in December 2014 that aims to help people in Europe to live a healthier life and stay active as they grow older. The consortium brings together 140 leading companies and institutions from 14 European countries and has a total budget of two billion euros. It is one of the largest networks worldwide in the healthcare sector.

  • Article - 21/01/2016

    DNA sequencing has become indispensable in modern science. Innovative advances that will bring about changes in the life sciences and medicine are due to rapid developments in genome analysis technologies. These technologies are increasingly being used in human diagnostics where they have made it possible to diagnose rare genetic diseases and analyse cancers. In the interview below, Peter Pohl, CEO and co-founder of GATC Biotech AG, explains why…

  • Article - 11/01/2016

    People with obesity suffer from more than just health problems related to their weight. They often feel socially stigmatised because their disease is often seen as a self-inflicted condition. A new study by the University of Hohenheim in cooperation with the eSwiss Medical and Surgical Center in St. Gallen now shows that severe obesity is closely associated with gene activity in the intestinal tissue. This activity is responsible for producing…

  • Article - 17/11/2015

    In the ”NanoBioMater”project house, researchers from the University of Stuttgart are working to develop novel hydrogels with integrated biocompatible scaffold structures. Their aim is to make the materials suitable for producing innovative components for environmental and food analytics as well as medical applications. The hydrogels could potentially be used in diagnostic biosensors and the controlled release of medical compounds.

Website address: https://www.gesundheitsindustrie-bw.de/en/article/diagnostics